Clinical Trial Update: Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dextromethorphan for Parkinson's disease and related neurodegenerative conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Dextromethorphan (dextromethorphan)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Neurodegenerative Disease, Parkinson's Disease | Phase 2 | Status: COMPLETED